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SUMMARY
Active metabolism regulates oocyte cell death via calcium/calmodulin-dependent protein kinase II
(CaMKII) mediated phosphorylation of caspase-2, but the link between metabolic activity and
CaMKII is poorly understood. Here we identify coenzyme A (CoA) as the key metabolic signal
that inhibits Xenopus laevis oocyte apoptosis, in a novel mechanism of CaMKII activation. We
found that CoA directly binds to the CaMKII regulatory domain in the absence of Ca2+ to activate
CaMKII in a calmodulin-dependent manner. Furthermore, we show that CoA inhibits apoptosis
not only in X. laevis oocytes, but also in Murine oocytes. These findings uncover a novel
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mechanism of CaMKII regulation by metabolism and further highlight the importance of
metabolism in preserving oocyte viability.
INTRODUCTION
The dogma that primary oocytes formed at birth are a nonrenewable source of eggs was
challenged by the discovery of proliferative germ cells that sustain oocyte and follicle
production(Johnson et al. 2004). Nevertheless, the number of mature oocytes that eventually
ovulate as an egg over the menstrual lifespan of a woman remains fixed at approximately
400 (Gosden 2005). Age-related aneuploidy, chemotherapy treatment, or environmental
toxin insult causes death, or atresia, of vertebrate oocytes, which in turn leads to premature
menopause and infertility. Because the first birthrates for women aged 35–44 years have
increased eightfold, there is a renewed interest in developing oocyte-preserving strategies.
One way to prevent oocyte atresia is by inhibiting specific proteins in the cell death pathway
(Gosden 2005); Lobo 2005). The first evidence that dormant female germ cells possess the
machinery for programmed cell death was the demonstration of doxorubicin-induced
apoptosis in vertebrate oocytes (Perez et al. 1997). We also reported that nutrient deprivation
induces apoptosis of vertebrate oocytes via activation of caspase-2(Nutt et al. 2005;Nutt et
al. 2009). This is particularly interesting because the primary phenotype of caspase-2
knockout mice is excess accumulation of oocytes that are resistant to doxorubicin-induced
cell death, suggesting that vertebrate oocytes are particularly susceptible to caspase-2–
mediated death (Bergeron et al. 1998). While exploring the links between metabolism and
caspase-2, we discovered that the addition of NADPH/glucose 6-phosphate (G6P) to oocyte
extracts generates an unidentified metabolic factor which suppresses the initiation of the
apoptotic signaling cascade by activating calcium/calmodulin-dependent protein kinase II
(CaMKII) (Nutt et al. 2005). CaMKII activation by NADPH/G6P was independent of an
increase in cytosolic Ca2+, suggesting the involvement of a novel non-canonical pathway.
The four CaMKII isoforms (α, β, γ, and δ) form a family of multifunctional serine/threonine
protein kinases that are important in many signaling cascades ranging from learning and
memory to the exit from mitosis. CaMKII exists as a homo-or hetero-dodecamer (Hudmon
& Schulman 2002). Ca2+/calmodulin (CAM)-stimulated autophosphorylation at
Thr-286/287 - the canonical CaMKII activation pathway - results in formation of a
constitutively active form of CaMKII that is essential for normal signaling. Targeted,
isoform-specific deletion of CaMKII results in very specific and diverse phenotypes in mice,
but CaMKIIγ−/− mice are uniquely infertile because of egg-activation defects(Backs et al.
2010). The biochemistry detailing the requirement for CaMKII in egg activation was first
demonstrated using the Xenopus egg. Our previous data further demonstrate that in X. laevis
oocytes CaMKII is a hetero-dodecamer, composed of multiple isoforms (McCoy et al.
2013).
Although genetic analyses in mice have improved our understanding of vertebrate infertility,
most vertebrate oocytes are not amenable to biochemical analysis due to their small size and
limited abundance. To identify the NADPH/G6P–dependent factor(s) required for CaMKII
activation, we used the biochemically tractable X. laevis egg extract and oocyte in this study.
Using cellular fractionation and unbiased metabolomics, we showed that addition of G6P to
X. laevis egg extracts preserved and increased cytosolic free CoA levels. We found that free
CoA directly binds to the calmodulin binding domain(CAMBD) of CaMKII to promote
CAM binding and activation of CaMKII in the absence of any increase in Ca2+. CaMKII
then phosphorylates caspase-2 at Ser135 and promotes oocyte survival. This is the first
evidence of CoA directly regulating CaMKII and oocyte survival. Furthermore, we provide
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strong evidence that this unique metabolic regulation of oocyte survival is evolutionarily
conserved in mammalian oocytes.
RESULTS
G6P-Induced CaMKII Activation Requires a Heat-Soluble Cytosolic Factor
Our earlier study showed that addition of G6P to X. laevis egg extracts increases NADPH
levels and suppresses oocyte death via CaMKII activation (Nutt et al. 2005). To test whether
NADPH directly activates CaMKII to suppress caspase-2 activation, NADPH was incubated
with recombinant CaMKIIα and CAM. As shown in Fig. 1A, addition of NADPH to
CaMKIIα and CAM did not activate CaMKIIα to phosphorylate caspase-2 at S135, unlike
Ca2+. This indicates that NADPH does not directly activate CaMKII to suppress apoptosis.
As a first step toward identification of G6P/NADPH–dependent factor(s) required for
CaMKII activation and the inhibition of apoptosis, G6P-treated and untreated egg extracts
were biochemically fractionated using a combination of heat precipitation and affinity
chromatography (Fig. 1B). CaMKIIα was added to heat soluble cytosolic fractions, and
CaMKII activity was determined by substrate phosphorylation of caspase-2 at S135. The
G6P-dependent factor(s) responsible for CaMKII activation was heat stable (Fig. 1C).
CAM is a well-known heat-stable activator of CaMKII. In order to determine the
contribution of CAM to CaMKII activation by the heat-soluble cytosolic fractions, we first
depleted CAM from the samples using a CAM-binding domain (CAMBD) peptide, amino
acids 290–309 of CaMKII, coupled to Sepharose. Depletion using CAMBD-Sepharose
markedly inhibited the activation of CaMKIIα, even when samples were supplemented with
CAM (Fig. 1D). These observations suggest that CAMBD-Sepharose may have depleted not
only CAM, but also other factors, from the heat-soluble fraction that may be involved in
CaMKII activation. Consistent with this idea, depletion of CAM using phenyl-Sepharose, a
hydrophobic resin classically used to purify CAM, also prevented CaMKII activation, but in
this case activation was restored by addition of CAM (Fig. 1D). However, serial depletion of
extracts, first by phenyl-Sepharose (to remove CAM) and then subsequently by CAMBD-
Sepharose, removed the metabolic factor required for CAM-dependent CaMKII activation
(Fig. 1D). In combination, these findings suggest that the heat-soluble cytosolic fraction of
X. laevis egg extracts contains two factors that are important for CaMKII activation; CAM,
which can be depleted by phenyl-Sepharose or CAMBD-Sepharose, in addition to another
heat-stable factor that is only depleted using CAMBD-Sepharose.
G6P Increases the Level of Cytosolic Coenzyme A
Initial proteomics-based efforts to identify the G6P-induced heat-soluble factor that
contributed to CaMKII activation were unsuccessful. Therefore, we used an unbiased
metabolomics approach to follow carbon flow in X. laevis egg extracts prior to (0 and 3
hours), and following (4 hours), caspase activation +/− G6P. Extracts were subjected to
high-speed centrifugation to remove light and heavy membranes, and cytosolic extracts were
analyzed. As expected, the levels of glucose, G6P, and glycolytic intermediates were
substantially higher in G6P-treated extracts compared to control extracts. Levels of
glucose-1-phosphate were also higher, perhaps implying an increase in glycogenesis which
has already been established in the X. laevis egg and oocyte (Nutt 2012). Intermediates of
the pentose phosphate pathway were also higher following G6P addition (Fig. S1&2). We
detected a significant increase in total levels of acetyl CoA in the G6Ptreated extracts (Fig.
2A). Moreover, adding acetyl CoA to egg extracts activated CaMKII as assessed by
caspase-2 phosphorylation and anti-T286/7 phospho-CaMKII immunoblot (Fig. 2B and C),
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and inhibited the activation of caspase-3 and caspase-2, similar to the effects of G6P (Fig.
2D and E).
Increased levels of cytosolic acetyl CoA have been detected in cancer (Wellen et al. 2009)
and can modify protein activity by acetylation. Although increased cytosolic acetyl CoA by
G6P increased global acetylation in the extract, we found no evidence that protein
acetylation was involved. Neither recombinant caspase-2 nor CaMKII were acetylated in the
presence of G6P, as assessed by immunoblotting with an acetyl-lysine antibody (data not
shown). Furthermore, mass spectrometric analysis for acetylation of CaMKII was negative
for total acetylation (data not shown). These observations suggest that G6P increases the
level of cytosolic acetyl CoA, which signals CaMKII activation in an acetylation-
independent manner. In order to define functional regions in the acetyl CoA structure, we
compared caspase-2 phosphorylation and caspase-3 activation following the addition of
CoA, acetyl CoA or acetate to extracts. CoA alone was sufficient to induce phosphorylation
of caspase-2 and suppress caspase-3 activation (Fig. 2F and G).
Chemical ablation of the rate-limiting enzyme required for CoA synthesis, panthothenate
kinase, did not override G6P-induced mediated inhibition of caspase activation or CaMKII
activation (Fig. 2H and I). The fact that CoA alone was sufficient to activate CaMKII and
inhibit apoptosis (Fig. 2F and G), and that acyl-CoA hydrolases/thioesterases are highly
active in vivo (Berge & Farstad 1979b; Knudsen et al. 1999) ,we then hypothesized that
acetyl CoA breakdown into CoA was the metabolic signal activating CaMKII. To test
whether the addition of G6P-induced an increase in acetyl CoA that may in turn be
hydrolyzed to produce cytosolic CoA, we performed LC/MS/MS analysis on heat soluble
cytosolic fractions of G6P and acetyl CoA treated extracts, measuring the levels of acetyl
CoA and CoA respectively. We found that similar to the result seen Fig. 2A G6P induced a
significant ~2.5 fold increase in acetyl CoA levels (Fig. 2J). Furthermore, treatment with
acetyl CoA resulted in a substantial increase in CoA levels (Fig. 2K). Taken together these
data demonstrate that G6P did not induce a de novo synthesis of CoA but rather indirectly
increased free CoA levels by increasing acetyl CoA synthesis, which in turn was hydrolyzed
to acetate and CoA.
CoA activates CaMKII and suppresses caspase activation
If CoA were the metabolic signal responsible for activation of CaMKII, then we would
predict that caspase activation in control extracts would be preceded by a decrease in levels
of CoA. Metabolomic analysis found that after 3 or 4 hrs incubation, the levels of free CoA
in control extracts had decreased by approximately 60%, whereas CoA levels in G6P treated
extracts had increased by approximately 50%. Thus, prior to caspase activation (4–6 hr in
control extracts – see Fig. 2D, F&H), free CoA levels were ~3-fold higher in G6P treated
extracts compared to control extracts (Fig. 3A). The correlation of CoA levels, in the
absence and presence of G6P, and CaMKII activity suggest that this co-factor may regulate
CaMKII and downstream regulation of caspase activation.
To examine whether CoA might play a role in CaMKII activation, CoA was titrated into
extracts. CoA increased caspase-2 phosphorylation in a concentration-dependent manner
(Fig. 3B), and also enhanced the phosphorylation of endogenous CaMKII at T286/287 (Fig.
3C), similar to G6P. The pattern of the three bands recognized by the phospho-Thr-286/287
antibody is similar to the pattern previously detected using a pan-CaMKII antibody that
recognizes the α, β, γ, and δ isoforms of CaMKII (McCoy et al. 2013). Depletion of CaMKII
from extracts using CAM-Sepharose inhibited the CoA-dependent phosphorylation of
caspase-2 (Fig. 3D), showing that CoAdependent phosphorylation of caspase-2 required
CaMKII. Thus, increasing the levels of CoA in egg extracts is sufficient to activate CaMKII.
Next we examined whether CoA-dependent CaMKII activation resulted in caspase-2 and
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caspase-3 inhibition similar to G6P. CoA supplementation of egg extracts inhibited the
activation of caspase-3 and caspase-2, similar to the effects of G6P (Fig. 3E&F). Taken
together these data show that maintenance of CoA levels sustains CaMKII activity to
suppress caspase activation in egg extracts.
Coenzyme A (CoA) directly binds endogenous CaMKII
Our biochemical data suggested that a heat-stable factor responsible for CaMKII activation
could bind to a CAMBD peptide (Fig. 1). Since CoA is heat-stable and also plays a role in
CaMKII activation (Fig. 2&3), we tested the hypothesis that CoA can directly bind to
CaMKII. CoA, acetyl CoA, or NADPH were immobilized on Sepharose and incubated with
egg extracts. Isolated complexes were analyzed by immunoblotting using the phospho-
Thr286/7 specific antibody that detected multiple activated CaMKII isoforms, and a total
CaMKII antibody. Fig. 4A shows endogenous CaMKII bound effectively to CoA-
Sepharose, while the binding to acetyl CoA-Sepharose was very weak and could only be
detected after prolonged film exposure. In contrast, there was no detectable binding to
NADPH-Sepharose. This demonstrates that the CoA moiety alone is sufficient to bind
CaMKII. To further examine the specificity of this interaction, CaMKII was depleted from
extracts using CAM-Sepharose, or mock depleted with Sepharose. These depleted extracts
were then incubated with Sepharose or CoA-Sepharose. Proteins recognized by two
different antibodies were specifically detected bound to CoA-Sepharose from control
extracts, but not from extracts depleted of CaMKII (Fig. 4B). Interestingly, based on the
reactivity of the anti-panCaMKII antibody, multiple CaMKII isoforms appeared to interact
with CoA-Sepharose. Moreover, binding of CaMKII to CoA-Sepharose was blocked by the
prior addition of excess exogenous CoA to the extracts (Fig. 4C). Furthermore, excess
exogenous CoA was able to displace CaMKII from an isolated complex with CoA-
Sepharose (Fig. 4D). Together, these data establish the specificity of the CoA–CaMKII
interaction in egg extracts.
Next, we examined the interaction between a fluorescent CoA derivative (CoA-488) and
recombinant His-tagged CaMKIIα, labeled using a terbium (Tb)-conjugated anti-HIS tag
antibody (Tb-anti-His), by time-resolved fluorescence resonance energy transfer (TR-FRET)
analysis. A CoA-488 concentration-dependent increase in TR-FRET was markedly
suppressed by inclusion of excess free CoA (Fig. 4E). The difference between these two
data sets was plotted as the specific binding curve yielding an apparent Kd of 593±169 nM
(mean±sem, n=4). Free CoA was able to suppress the TR-FRET signal in a concentration-
dependent manner (Fig. 4F). Moreover, the TR-FRET signal was also suppressed by
increasing concentrations of the CAMBD peptide, but not of a scrambled control peptide
(Fig. 4F). Moreover, the CAMBD peptide also competed for recombinant mouse CaMKIIα
binding to CoA-Sepharose in a concentration-dependent manner, completely preventing the
interaction at concentrations >100 µM (Fig. 4G). These data show that CoA directly binds to
CaMKII by a mechanism that may involve residues 290–309 in the CaMKII regulatory
domain.
Activation of CaMKII induced by CoA Requires basal Ca2+/CAM
Since the CAMBD of CaMKII appears to interact with both CAM and CoA, we investigated
the potential impact of CAM on the interaction with CoA. First, increasing concentrations of
purified CaMKII or recombinant CaMKIIα were incubated with CoA-Sepharose in the
absence or presence of CAM. CAM appeared to have no substantial impact on the
interaction of either CaMKII preparation with CoA-Sepharose (Fig. 5A&B). The experiment
in Fig. 5B was conducted in the presence of 50 µM EGTA, however this was likely not
enough to completely chelate the Ca2+ that typically contaminates all aqueous buffers. To
confirm that CoA could bind directly to CaMKII independently of Ca2+, high concentrations
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of EGTA (2 mM) were used in the experiments shown in Fig. 5C, demonstrating that CoA-
Sepharose can directly bind both CaMKIIα and CaMKIIγ isoforms independently of Ca2+.
We next examined the ability of CoA, acetyl CoA and a stable CoA-thioester (CoA-
propan-2-1) (Fig. S3) to directly activate CaMKIIα. While CoA stimulated CaMKII
phosphorylation of caspase-2, acetyl CoA was a very weak CaMKII activator and
CoApropan-2-1 did not detectably activate CaMKII (Fig. 5D). Taken together these results
demonstrate that the CoA moiety is sufficient to result in CaMKII activation, and that
modification of CoA, including esterification, disrupts the activation of CaMKII.
To determine whether CaMKII activation by CoA required CAM, we repeated the
experiment above with or without CAM. The addition of CAM or CoA alone had no affect
on CaMKII activity; however the combined addition of CoA and CAM activated CaMKII to
a similar degree as saturated Ca2+/CAM (Fig. 5E). CoA, in the presence of CAM, was also
capable of activating both CaMKIIα and CaMKIIγ in the presence of low EGTA (100 µM)
(Fig. 5F). Although Ca2+ is not required for CoA binding to CaMKII, we wanted to
determine whether the CoA-CAM dependent activation of CaMKII required the low levels
of free Ca2+ that are likely present in these buffers in the presence of low EGTA. Therefore,
increasing concentrations of EGTA were titrated to determine whether free Ca2+ was
required for CoA-dependent activation of CaMKII. Fig. 5G shows that CaMKII activity was
significantly suppressed at 500 µM and 1 mM EGTA. Therefore, CoA-induced CaMKII
activation requires CAM and low concentrations of Ca2+ (basal Ca2+/CAM), effectively
lowering the threshold for the amount of Ca2+ required by CAM to activate CaMKII.
To determine the amount of free Ca2+ required for CoA-dependent CaMKII activation,
CaMKII activity was measured in the presence of a fixed concentration of EGTA (1 mM).
We then titrated in known concentrations of “total” CaCl2, resulting in CaMKII activation
following addition of even 4 µM total Ca2+ (Fig. 5H) Using the Stanford Ca-EGTA
calculator (http://maxchelator.stanford.edu/CaMgATPEGTA-TS.htm), the estimated free
Ca2+ concentration with 4 µM total Ca2+ and 1 mM EGTA under these conditions is 2.4 nM.
However, the likely contamination of our buffers by about 20 µM Ca2+ would increase free
Ca2+ concentrations to approximately 15 nM. Thus, we conclude that low nM
concentrations of Ca2+ that are typically present under basal cellular conditions partially
saturate CAM (basal Ca2+/CAM) and are required to support CoA-induced CaMKII
activation, but that an increase in Ca2+ is not required.
Activation of CaMKII by Ca2+/CAM is cooperative, with a Hill coefficient ranging from 1.0
– 5.0 depending on the isoform and substrate used (Chao et al. 2010; Bradshaw et al. 2003).
To examine whether CaMKII activation by CoA/CAM was also cooperative, we
investigated the CoA concentration-dependence of CaMKIIα activation in the absence of
added Ca2+ (basal Ca2+/CAM), based on substrate phosphorylation of GST-pro C2 (Fig. 5I)
and autophosphorylation of CaMKIIα itself (Fig. 5J). The Hill coefficients (mean±sem,
n=2) were 1.5±0.3 and 1.4±0.5, respectively, indicating moderate cooperativity under these
conditions. Furthermore, the Ka values (mean±sem, n=2) were 1.8±0.1 mM for GST-pro C2
and 0.85±0.06 mM for CaMKII phosphorylation. Together, these data demonstrate a novel,
non-canonical mechanism for activation of CaMKII by CoA and CAM at low/basal levels of
free Ca2+.
Modeling the CoA binding site on CaMKIIα
We exploited the available X-ray crystal structures of CaMKIIα(PDB:3SOA), docking
algorithms with evidence that CoA interacts with the CAMBD of CaMKII, and knowledge
of typical adenine ring interactions with proteins (Kuttner et al. 2003) to build a robust
model of the CoA-CaMKII interaction. This model was relaxed by molecular dynamics
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(MD) simulations (Fig. 6A–C). Our model predicts that the adenine ring of CoA occupies a
hydrophobic pocket near L308 and makes two interactions with R300: the adenine ring
stacks tightly on top of the alkyl side chain and the NH2 makes a hydrogen bond to the
peptide backbone carbonyl. The 3’ phosphate interacts with the backbone amine of T310.
The guanidine group on R296 and amino group on K300 stabilize the CoA diphosphate
moiety. The pantothenate segment stacks against W214, while F293 and K292 cradle the
Cys-derived segment of CoA. MD simulations reveal that addition of an acetyl group to
CoA increases ligand flexibility and disrupts binding to CaMKII by destabilizing the
hydrogen bond between CoA O44 and R296 (Fig. 6D, Table S1). Our data showing that the
CoA moiety alone was capable of binding to and activating CaMKII (Fig. 4A&5D), and
inhibiting apoptosis (Fig. 2F&G), validates this model. Taken together these data show that
CoA acylation reduces binding to CaMKII.
To determine how the interaction between CoA and the CAMBD might facilitate CaMKII
activation by CAM, we used MD simulations to relax the regulatory domain conformation
upon CoA binding (Fig. 6C). CoA remained bound to CaMKII in five independent
simulations. The CoA di-phosphate group continues to make hydrogen-bond interactions
with the side chains of R296 and K300. The α-helix formed by residues 295- 300 becomes
partially unwound to become a β-turn, whereas the remainder of the protein retains its
structure. This occurred in all five simulations and was quantified by measuring the residue-
wise secondary structural propensities during the MD production runs (Fig. S5). No such
changes were observed in the absence of CoA. The conformational change resulting from
this unwinding of the α-helix may be detectable by glycerol-gradient sedimentation.
Incubation of CaMKIIα and CAM with CoA resulted in a modest shift in the size of
CaMKII (Fig. S6B), as assessed on a 15–45% glycerol gradient. Taken together, this data
supports the hypothesis that CoA binding destabilizes the secondary structure of residues
295–300. Destabilization of the regulatory domain structure may facilitate interactions with
CAM under basal conditions when only 1 or 2 Ca2+ ions are bound to CAM. Since a
previous study found that CAM with only 2 Ca2+ ions bound in the C-terminal domain can
partially activate CaMKII (Shifman et al. 2006), we speculate that this then results in
CaMKII activation.
The crystal structure of Ca2+/CAM bound to CaMKIIδ(PDB ID: 2WEL) (Rellos et al. 2010)
represents the activated form of CaMKII. In contrast to our model of CoA bound to the auto-
inhibited form of CaMKII, K292 is solvent exposed, F293 is reoriented and buried into
CAM, and R296 and K300 form salt bridges with negatively charged residues on CAM.
Upon superposition of the auto-inhibited CaMKII-CoA dock pose onto the activated
CaMKII-CAM bound form, the pocket for the CoA adenine ring is abolished by the
protrusion of L304 (Fig. S4A&B). Moreover, to maintain interactions made by CoA ribose,
diphosphate and pantothenate parts, residues R296 and K300 of CaMKII, and residues E8,
E12, M145 and M146 of CAM would have to be rearranged. Therefore our model suggests
that simultaneous binding of CoA and Ca2+/CAM to CaMKII is unlikely. We validated this
by showing that an excess of Ca2+/CAM displaced CaMKII from CoA-Sepharose (Fig. 6E,
Fig. S6A). We cannot rule out the possibility of a transitional CaMKII-CoA-basal Ca2+/
CAM complex. Moreover, our modeling cannot address whether CoA and CAM that is not
fully saturated with Ca2+ can bind simultaneously to the CaMKII regulatory domain since
structures of basal Ca2+/CAM or apo-CAM bound to CaMKII are not available.
Our modeling suggests that residues K292, R296, and K300 are required for CoA binding.
Triple A mutants were made in the CAMBD of full-length CaMKIIα. CoA-Sepharose
bound significantly less to the triple A mutant K292A/R296A/K300A CaMKIIα compared
to WT CaMKIIα from cell lysates of HEK-293T cells overexpressing either the WT
CaMKIIα or triple CaMKIIα mutant (Fig. 6F). Onedimensional 1H and 31P NMR also
McCoy et al. Page 7
Mol Cell. Author manuscript; available in PMC 2014 November 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
showed that, compared to WT CAMBD, the triple mutant bound CoA weakly as indicated
by smaller chemical shift perturbations observed during titrations (Fig. 6H). Moreover, the
triple mutant CAMBD peptide did not inhibit binding of CoA-Sepharose to recombinant
mouse CaMKIIα (Fig. S6C&D). Taken together, these biochemical data strongly support
the prediction that amino acids K292, R296, and K300 are important for binding of CaMKII
to CoA.
NMR-guided modeling of CoA binding site on CaMKII
The interactions between the CAMBD peptide and CoA were probed by NMR spectroscopy.
Assignments for CoA and the CAMBD peptides are shown in tables S3–5 and fig. 6G. NMR
titrations of CoA with CAMBD indicated a weak affinity for this interaction with a Kd in the
0.9 mM range (Fig. S6E). Comparison of the 15N–1H HSQC spectra of free and bound
CAMBD indicated significant chemical shift perturbations of the backbone amides upon
CoA binding observed throughout the peptide, with exception of three residues at the N-
terminus and A302 (Fig. 6G). Protons of CoA that showed chemical shift perturbations were
in the adenine ring, ribose sugar group and the two methyl groups of the panthothenate
moiety (Fig. S6E & F, Fig. S7B and Table S5). In the 31P spectra, the 5’ diphosphate moiety
showed reduced chemical shift perturbations compared to the 3’ phosphate, although they
both displayed similar kinetics of binding with a Kd in the 0.4 mM range (Fig. 6H).
We also tested binding of CoA to full-length CaMKIIα by one-dimensional relaxation-
edited 1H NMR. In the relaxation-edited spectra, some of the CoA signals are attenuated as
CoA forms a complex with the large dodecameric CaMKIIα and therefore relaxes much
faster than free CoA. The relaxation-edited difference spectrum between free and CaMKII-
bound CoA indicated potential additional contributions to binding also from protons of the
cysteine and panthothenate moieties (Fig. S7A), attributed to CoA interactions to CaMKII
outside the CAMBD region. This provides direct NMR evidence for the interaction between
CoA and CaMKII.
Coenzyme A Inhibits DHEA-Induced Apoptosis in Xenopus and Murine Oocytes
To determine whether CoA could activate CaMKII and suppress apoptosis in intact X. laevis
oocytes. Our previous data showed that nutrient depletion induced by trans-
dehydroandrosterone (DHEA) was sufficient to induce X. laevis oocyte death by a caspase-2
dependent mechanism (Nutt et al. 2005). DHEA induced oocyte apoptosis in a dose-
dependent manner (Fig. 7A), and prior injection of CoA inhibited this DHEA-induced
oocyte death (Fig. 7B). Moreover, the inhibitory effect of CoA was blocked by co-injection
of the CAMBD peptide (Fig. 7C). Likewise, DHEA induced caspase activation in aged
mouse oocytes (Fig. 7D); caspase activation and mouse oocyte death was also inhibited by
prior injection of CoA (Fig. 7E, Table 1). Taken together, these findings are consistent with
a model in which active metabolism maintains high levels of CoA that protect against the
death of vertebrate oocytes by binding to the CaMKII regulatory domain to stimulate
phosphorylation of the caspase-2. Furthermore, metabolic suppression of oocyte death by
maintenance of CoA levels is conserved across vertebrates.
DISCUSSION
We have previously identified a novel link between G6P-induced pentose phosphate
pathway generation of NADPH and the cell death machinery (Nutt et al. 2005; Nutt et al.
2009; McCoy et al. 2013). We postulated that G6P/NADPH induced an active signaling
system to keep these cells alive and that the default pathway, when key metabolites cannot
be maintained, is cell death. In the current study, we identify the levels of CoA as a key
metabolite that activates CaMKII and suppresses oocyte/egg extract apoptosis. These
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findings highlight the importance of maintaining oocyte metabolism to preserve egg
viability and fertility.
CoA is an essential cofactor that is found in all living organisms. Although first recognized
for its role in acetylation reactions, CoA functions as an obligate cofactor in many
intermediary metabolic steps. The intracellular ratio of free CoA to acyl-CoAs is tightly
controlled by several mechanisms. Most CoA is concentrated in the mitochondria, where it
is required for the citric acid cycle, β-oxidation, and ketogenesis (Leonardi et al. 2005).
However, the 5-step CoA-synthesis pathway is localized to the cytosol, and a CoA
transporter is required to shuttle CoA into mitochondria. In the first biosynthetic step,
vitamin B5 (pantothenic acid) is converted to 4’ phosphopanthothenic acid by pantothenate
kinase (Pank), the rate-limiting enzyme in CoA synthesis. Pank has 4 human isoforms, but
deletion of Pank2 leads to infertility. Mating of homozygous Pank2 females with wild-type
males led to a decrease in Mendelian expectancy in the viable offspring. In contrast, mating
of Pank2 males with WT females led to no viable mice because of azoospermia (Kuo 2004).
These data provide strong genetic evidence for a link between CoA synthesis and
preservation of fertility. Interestingly, we have ruled out the role of Pank by chemical
ablation with Hopantenate (HoPAN), a robust inhibitor of Pank (Zhang et al. 2007). HoPAN
treatment did not affect G6P-mediated CaMKII activation or inhibition of apoptosis. In fact
our data show a novel stockpile of CoA in the form of acetyl CoA, also it is known that high
activity of acyl-CoA hydrolases/thioesterases occur in vivo (Berge & Farstad 1979a;
Knudsen et al. 1999). Moreover, acetyl CoA is normally found in mitochondria so our
results showing that G6P-induces a significant increase of acetyl CoA in the cytosol
implicates a novel metabolic circuit regulating cytosolic CoA levels, CaMKII activation, and
oocyte/egg survival.
The addition of CoA recapitulated the anti-apoptotic effects of G6P at the level of CaMKII,
caspase-2, and caspase-3. The concentrations of CoA added to the extract and recombinant
proteins are similar to the reported cytosolic concentrations of CoA in other tissues
(Robishaw & Neely 1985). Thus, our observation is physiologically relevant. However,
under physiological conditions, mM concentrations of CoA are concentrated in the
mitochondria, and are required for the citric acid cycle, β-oxidation, and ketogenesis
(Leonardi et al. 2005). Interestingly, the mitochondria are also the signaling hub for
apoptosis (Danial & Korsmeyer 2004). In X. laevis oocytes, caspase-2 is dormant in fresh
extracts. As mitochondria are a sink for CoA we speculate that in the absence of active
metabolism, mitochondria sequester CoA from the cytosol, thereby inhibiting CaMKII. This
decrease in cytosolic CoA and subsequent CaMKII inhibition results in caspase-2
dephosphorylation and subsequent oocyte/egg apoptosis. Our finding that addition of G6P
not only stabilizes but also increases cytosolic CoA levels provides a mechanism for G6P-
mediated oocyte survival.
We propose a key part of this effect is mediated by the non-canonical CoA-dependent
activation of CaMKII. There are other examples of calcium-independent CaMKII
regulation, such as proteolytic cleavage of the regulatory domain (Rich et al. 1990;
Kwiatkowski & King 1989). Secondly, recent studies found that CaMKII can be activated
by calcium-independent binding of α-actinin (Jalan-Sakrikar et al. 2012). Finally, it has been
shown that oxidation of two key methionine residues (M281 and M282) in the CaMKII
regulatory domain can activate CaMKII in the absence of T286 phosphorylation (Erickson
et al. 2008). Our data differs from the above in that CoA-induced CaMKII requires basal
amounts of calcium. Hence, while an increase in Ca2+ is not required, low basal
concentrations of Ca2+ are sufficient to support CoA-dependent activation of CaMKII.
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Our molecular model of CoA binding to CaMKIIα is consistent with the experimental
observations reported herein. The majority of the protein-ligand interactions in the model are
made with the protein region spanning residues 290–309, and this peptide has been shown to
be sufficient to outcompete CoA binding to full-length CaMKIIα. Acyl substitutions on
CoA decrease CaMKIIα activation according to the trend CoA>acetyl-CoA>CoA-propan-2-
one. In our model, the CoA sulfhydryl is oriented away from protein and towards bulk
solvent where there are no accessible hydrophobic pockets. From the results of our MD
simulations, we propose that modifications at this end of CoA increase ligand flexibility and
disrupt binding to full-length CaMKII by destabilizing the hydrogen bond between CoA
O44 and R296. These results would explain why we see the inability of acetyl CoA to bind
or induce activation of CaMKII to the same extent as CoA.
Our modeling data implicate Lys292, Arg296, and Lys300 within the CAM-binding domain
as key determinants of CoA binding. The NMR analysis of CoA–CAMBD peptide
supported their contribution, which was further corroborated by the diminished interaction
of CoA to this triple mutant CAMBD peptide. CaMKII has been extensively mutated in this
region to identify regulatory determinants. A peptide-based mutagenesis study from 1992
investigated the importance of individual residues in regulating inhibitory interactions with
the kinase domain (Smith et al. 1992). While mutations of Lys291, Arg297 and Lys298
displayed at least a 10-fold loss of potency, mutations of Lys292, Arg296 and Lys300 had a
modest effect. Similarly, another study from 1999 investigated residues important in the
auto-inhibitory interactions of the CaMKII kinase domain and regulatory domain. Mutations
E285K, R296E, R298E, and K300E required significantly more Ca2+ to achieve half-
maximal kinase activity. The mutations D288K, K292E, and R297E, on the other hand,
exhibited no significant changes in calmodulin binding affinity (Yang & Schulman 1999).
Together, these data suggest that Lys292, Arg296 and Lys300 are largely solvent exposed,
consistent with them being available for interaction with CoA, as predicted in our model and
observed biochemically.
Studies using synthetic peptides and the intact CaMKII holoenzyme have yielded an
excellent structural understanding of the interactions of saturated Ca2+/CAM with the
CaMKII regulatory domain. However, the potential for interactions of apo-CaM, or basal
Ca2+/CAM, with CaMKII are poorly understood. Our MD simulations show that CoA
binding induces conformational changes in the C-terminal portion of the CaMKII regulatory
domain, and this increased conformational flexibility may facilitate binding of perhaps basal
Ca2+/CAM. Alternatively, local conformational changes induced by CoA binding to the
regulatory domain may have more far-ranging consequences to the CaMKII holoenzyme
structure. Recent structural studies of CaMKII suggest that the kinase domains can adopt
multiple conformations relative to the dodecameric hub of the holoenzyme. In one structure
the kinase domains appear to be in a compact conformation stabilized by interactions of
portions of the regulatory domain with the hub of the holoenzyme. This conformation
“shields” the regulatory domain from apo-CAM and basal Ca2+/CAM (Hudmon &
Schulman 2002; Chao et al. 2011). Thus, one alternative hypothesis is that binding of CoA
to the regulatory domains may destabilize the compact structure to promote a more extended
kinase domain conformation that is more readily activated by basal Ca2+/CAM. In essence,
CoA acts as a wedge between the regulatory and Hub domains, destabilizing the secondary
structure of the regulatory domain enough to expose C-terminal residues such that basal
Ca2+/CAM can bind and displace CoA. Furthermore, our model predicted CoA binding
decreased alpha helical propensity at residues 295–300 and our biochemical data
demonstrating the ability of CoA to alter the sedimentation properties of CaMKII in a
glycerol gradient support this model.
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The study of metabolic regulation in mammalian cells is cumbersome, as it is not feasible to
introduce intermediate metabolites directly into cells unless by microinjection. Therefore,
using the Xenopus oocyte model allowed us to discover a novel connection between
metabolism and oocyte viability. A better understanding of the molecular mechanisms
underlying these links might provide the basis for developing novel strategies for CoA in
promoting oocytes longevity for increased fertility.
EXPERIMENTAL PROCEDURES
Preparation of Xenopus Oocytes, Extracts, Cytosols
Mature female frogs were induced to lay eggs as previously described (Smythe & Newport
1991). Egg extracts were prepared as described previously (Nutt et al. 2009).
Stage VI oocytes were harvested from mature female frogs as described previously (Nutt et
al. 2009). Healthy stage VI oocytes were selected for microinjection and treatment.
Recombinant Protein Cloning and Expression
N-terminally GST-tagged (pGEX-KG) Xenopus wild type caspase-2 pro-domain was
expressed in, and purified from, BL21 E. coli as previously described (E. K. Evans et al.
1997). Xenopus caspase-2 constructs were cloned into pGEX-KG and pSP64T as previously
described (Nutt et al. 2005). Recombinant mouse CaMKIIα was prepared as described
previously (Brickey et al. 1990). Mouse CaMKIIα WT and K292A/R296A/K300A mutant
constructs (pcDNA3) for transfecting into HEK-293T cells were generated using primers
described in Extended Experimental Procedures.
Caspase 3/7 Assay
Caspase-3/7 activity in extracts was analyzed similar to as previously described (Nutt et al
2005). For this study, a luminescent substrate (Caspase-Glo 3/7 Assay, Promega) was used.
Kinase Assays
GST-tagged Xenopus caspase-2 pro-domain (GST-pro C2) bound to glutathione- Sepharose
was incubated in egg extract, cytosol or heat soluble cytosol with 5 µCi [γ-32P]ATP, ±
indicated treatments for 2 hours (unless otherwise stated) at room temp. GSTPro C2 beads
were analyzed by autoradiography.
In vitro kinase assays were performed by incubating glutathione-Sepharose bound GSTpro
C2 in kinase buffer with, CaMKII ± calmodulin, in the presence of 5µCi [γ-32P]ATP.
Reactions were incubated ± EGTA and ± indicated treatments at room temp. for 30 min.
Coupled-Sepharose Binding Assays
CoA, acetyl CoA, NADPH or CAM conjugated to Sepharose were incubated in egg extract
for 45 min. at room temp. Beads were washed and analyzed by immunoblotting.
In vitro binding experiments were performed by incubating CoA-Sepharose, or CAM-
Sepharose in kinase buffer with unless otherwise stated, mouse CaMKIIα ± calmodulin, for
30 min. at room temp, ± EGTA. For CAM-Sepharose binding, kinase buffer was
supplemented with CaCl2. Beads were washed and analyzed by SDS-PAGE and
immunoblotting.
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Xenopus Oocyte Microinjections
Stage VI oocytes were microinjected with either vehicle control 5 mM CoA, 20 mM CoA,
or 20 mM CoA and 1mM CAMBD. Injected oocytes were subsequently incubated with
vehicle control or indicated concentrations of DHEA in OR-2 buffer (Nutt et al 2009), at
18°C and monitored for induction of apoptosis.
Extended Experimental Procedures
Additional and more detailed experimental procedures, including a list of antibodies and
reagents used, can be found in the Supplemental Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• CoA directly binds to the regulatory domain of CaMKII.
• CoA activates CaMKII in a calmodulin-dependent manner.
• CoA inhibits apoptosis in both X. laevis and Murine oocytes.
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Figure 1. G6P activates a heat soluble cytosolic factor responsible for CaMKII activation
A) Glutathione-Sepharose bound caspase-2 pro-domain (GST-pro C2) was incubated in
kinase buffer with [γ-32P]ATP, CaMKIIα, CAM, ± 5 mM NADPH or 50 µM CaCl2. Beads
were analyzed by autoradiography. n= 2.
B) Scheme used to characterize the factor responsible for CaMKII activation.
C) GST-pro C2 was incubated in heat soluble cytosol prepared ± G6P, supplemented with
CaMKIIα in the presence of [γ-32P]ATP. Beads were analyzed as in panel A. n≥3.
D) (Top panel) GST-pro C2 was incubated in heat soluble cytosols depleted with either
Phenyl-Sepharose, CAMBD-Sepharose, or serially depleted with Phenyl-Sepharose
followed by CAMBD-Sepharose, with CaMKIIα, [γ-32P]ATP, ± CAM for 30 min. Beads
were analyzed as in panel A. (Lower panel) Depletion of CAM was confirmed by
immunoblotting. n≥3.
McCoy et al. Page 16
Mol Cell. Author manuscript; available in PMC 2014 November 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. G6P increases cytosolic levels of acetyl CoA
A) Cytosolic acetyl CoA levels of extracts treated ± G6P were measured at 0 hr. Each bar
represents mean ± S.E. of n= 5. * indicates a p-value <0.05. Also see Figs. S1&2.
B) GST-pro C2 was incubated in extract with 10 mM acetyl CoA or 20 mM G6P, and
[γ-32P]ATP. Beads were analyzed by autoradiography. n≥3.
C) Extracts were incubated with 10 mM acetyl CoA, or 20 mM G6P, for 2 hrs. Samples
were immunoblotted for pCaMKII T286/287 and total CaMKII. n≥3.
D) Extracts were incubated with 10mM acetyl CoA or 20 mM G6P. Samples were taken at
indicated times and analyzed for caspase-3/7 activity. n≥3.
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E) Extracts supplemented with 35S-labeled caspase-2, was incubated ± 10 mM acetyl CoA
or 20 mM G6P. Samples were taken at indicated times and analyzed by autoradiography.
Note appearance of cleaved caspase-2 products at 4–6 hours in control samples, and their
absence in G6P and acetyl CoA samples. n=2.
F) Extracts were incubated with CoA, acetyl CoA, acetate (all 10 mM) or 20 mM G6P.
Samples were taken at indicated times and analyzed for caspase-3/7 activity. n=2.
G) GST-pro C2 was incubated in extract with CoA, acetyl CoA or acetate (all 10 mM), and
[γ-32P]ATP. Beads were analyzed by autoradiography. n=2.
H) Extracts were incubated with 20 mM G6P alone, 200 µM HoPan alone, or G6P+HoPan.
Samples were taken at indicated times and analyzed for caspase-3/7 activity. n=2.
I) Glutathione-Sepharose bound GST-pro C2 was incubated in extract with 20 mM G6P
alone, 200 µM HoPan alone, or G6P+HoPan, and [γ-32P]ATP. Beads were analyzed by
autoradiography. n=2.
J) Heat soluble fractions of cytosols treated ± 20 mM G6P were prepared and acetyl CoA
levels analyzed by LC/MS/MC, using a method independent form that used in panel A. Each
bar represents mean ± S.E. of n= 3* indicates a p-value <0.05.
K) Heat soluble fractions of cytosols treated with or without 10 mM acetyl CoA were
prepared and CoA levels analyzed by LC/MS/MS, using a method independent form that
used in fig. 3A. Each bar represents mean ± S.E. of n= 3 * indicates a p-value <0.05.
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Figure 3. Increased cytosolic CoA following G6P activates CaMKII and inhibits apoptosis
A) Cytosolic CoA levels of extracts treated ± G6P were measured at indicated time points.
Each bar represents mean ± S.E. of n= 5, expressed as % of 0 hr (Control 0 hr and G6P 0 hr
respectively). * indicates a p-value <0.05 for G6P 3 and 4 hr relative to control.
B) GST-pro C2 was incubated in extract with indicated concentrations of CoA or 20 mM
G6P, and [γ-32P]ATP. Beads were analyzed by autoradiography. n≥3.
C) Extracts were incubated with 10 mM CoA, or 20 mM G6P, for 2 hrs. Samples were
immunoblotted for pCaMKII T286/287 and total CaMKII. n≥3.
D) (Top panel) 3 separate aliquots of extract were depleted using 3 separate bead amounts of
Sepharose or CAM-Sepharose. (Lower panel) GST-pro C2 was incubated in the depleted
extracts with [γ-32P]ATP ± 10 mM CoA. Beads were analyzed as in panel B. n= 2.
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E) Extracts were incubated with indicated concentrations of CoA or 20 mM G6P. Samples
were taken at indicated times and analyzed for caspase-3/7 activity. n≥3.
F) Extracts supplemented with 35S-labeled caspase-2, were incubated ± 10mM CoA or
20mM G6P. Samples were taken at indicated times and analyzed by autoradiography. Note
the appearance of cleaved caspase-2 products at 6 hours in control samples, and their
absence in G6P and CoA samples. n=2.
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Figure 4. CoA binds endogenous CaMKII in X. laevis egg extracts, and directly in vitro
A) CoA-Sepharose, acetyl CoA-Sepharose (Ac. CoA-Sepharose), NADPH-Sepharose,
CAM-Sepharose or Sepharose alone were incubated in extracts. Beads were immunoblotted
for CaMKII and pCaMKII T286/287. Two separate exposures are shown. n=3.
B) (Top panel) Extracts were depleted with Sepharose or CAM-Sepharose as in Fig. 2F.
(Lower panel) Depleted extracts were incubated with CoA-Sepharose or Sepharose alone
and analyzed as in panel A, but also immunoblotting with a panCaMKII antibody. n=2.
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C) CoA saturated egg extract blocks CaMKII binding to CoA. CoA-Sepharose or Sepharose
alone were incubated in extracts supplemented ± 40 mM CoA and analyzed as in panel A.
n=3
D) CoA-Sepharose or Sepharose alone were incubated in extracts, washed ± 25 mM CoA,
and analyzed as in panel A. n=2.
E) CoA-488 was incubated with His-CaMKIIα and Tb-anti-His, ± 100 µM CoA, and
analyzed by TR-FRET. A (filled circles) = an increase in FRET signal by CoA alone. B
(open squares) = excess CoA present. The difference between these two data sets was
plotted as the specific binding curve (A–B, filled diamonds) Each data point represents a
mean±S.D. of n=4.
F) CoA-488 was incubated with human His-CaMKIIα and Tb-anti-His, in the presence of
indicated concentrations of CoA, CAMBD, or calmodulin inhibitory control peptide and
analyzed by TR-FRET. Each data point represents a mean±S.D. of n=4.
G) CoA-Sepharose was incubated in kinase buffer with 30 nM CaMKIIα, and indicated
concentrations of CAMBD, in the presence of 50 µM EGTA. Beads were immunoblotted for
CaMKIIα. n=3.
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Figure 5. CaMKII activation induced by CoA requires basal Ca2+/CAM
A) CoA-Sepharose was incubated with indicated concentrations of rat brain purified
CaMKII ± CAM in kinase buffer. CAM-Sepharose was incubated with 100 nM of CaMKII
as a positive control (last lane). Beads were immunoblotted for CaMKII. n≥3.
B) The experiment from panel A was repeated using recombinant mouse CaMKIIα, and in
the presence of 50 µM EGTA. n≥3.
C) CoA-Sepharose was incubated with 65.6 nM of mouse CaMKIIα (left panel), or 65.6 nM
human GST-CaMKIIγ (right panel) in kinase buffer in the presence of 2 mM EGTA. Beads
were analyzed as in panel A. n=2.
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D) GST-pro C2 was incubated in kinase buffer with [γ-32P]ATP, mouse CaMKIIα, CAM
and either CoA, acetyl CoA (Ac. CoA) or CoA-propan-2-1 (all 10 mM), in the presence of
50 µM EGTA. Beads were analyzed by autoradiography. n=2 (also see Fig. S3).
E) GST-pro C2 was incubated in kinase buffer with [γ -32P]ATP and rat brain purified
CaMKII, ± CAM, 10 mM CoA or 500 µM CaCl2. Beads analyzed as in panel D. n≥3.
F) GST-pro C2 was incubated in kinase buffer with [γ-32P]ATP, mouse CaMKIIα (left),
human GST-CaMKIIγ (right), CAM and 10 mM CoA, in the presence of 100 µM EGTA.
Beads were analyzed as in panel D. n=2.
G) GST-pro C2 was incubated in kinase buffer with [γ-32P]ATP, mouse CaMKIIα, CAM,
10 mM CoA and indicated concentrations of EGTA. Beads were analyzed as in panel D.
n=3.
H) GST-pro C2 was incubated in kinase buffer with [γ-32P]ATP, CaMKIIα, CAM, CoA, ±
indicated concentrations of CaCl2, and either 100 µM EGTA or 1 mM EGTA. Beads were
analyzed as in panel D. n=3.
I) GST-pro C2 was incubated with [γ-32P]ATP, CaMKIIα, CAM and indicated
concentrations of CoA, in the presence of 50 µM EGTA. Beads were analyzed as in panel D.
Each data point represents mean ± S.E. of 2.
J) The same experiment as in panel H, assessing the phosphorylation of CaMKIIα. Each
data point represents mean ± S.E. of 2.
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Figure 6. CoA interacts with the CAMBD of CaMKII and requires residues K292/R296/K300
A) Pocket surface representation of the docked model of CaMKII-CoA. B) Wire
representation of pose in panel A highlighting protein residues that make direction
interactions with CoA. View has been rotated for clarity. C) CaMKIIα-CoA complex
(green) following MD simulation showing unwinding at the residues 295–300 of the
regulatory domain. The kinase domain is colored yellow, CAMBD as magenta, the Hub
domain is blue and CoA in grey. A portion of the CaMKIIα structure is hidden for clarity
(also see Fig. S4&5)
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D) Atom-wise Root Mean Square Fluctuations (RMSF) of CoA (Red) and acetyl-CoA
(Blue) averaged over five MD independent simulations. Each data point represents the mean
of 5 independent simulations.
E) CoA-Sepharose beads were incubated in kinase buffer with 100 nM CaMKIIα, in the
presence of 100 µM EGTA and absence of CaCl2/CAM, or in the presence of 1 mM CaCl2
and 1 µM calmodulin and absence of EGTA. Beads were immunoblotted for CaMKII. n=2.
F) Lysates of HEK-293T cells transfected with wild type (WT) mouse CaMKIIα, or mouse
CaMKIIα K292A/R296A/K300A (AAA) were incubated with CoA-Sepharose, or
Sepharose, in the presence of 2 mM EGTA. Beads were analyzed as in panel E. Input
samples were also blotted for CaMKII to confirm equal transfection efficiencies. n≥3.
G) (Top panel) 15N–1H HSQC spectra of 2 mM WT CAMBD peptide ± 10-fold excess CoA
measured using the natural abundance of the 15N isotope. (Lower panel) 15N–1H chemical
shift perturbations (CSPs) versus CAMBD residue numbers for the samples above.
H) 31P NMR titrations of 200 µM CoA with 1, 2, 5 molar equivalents of WT and K292A/
R296A/K300A mutant CAMBD peptide. (see Supp. Figs. 6&7).
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Figure 7. CoA inhibits DHEA induced death in Xenopus and mouse oocytes
A) Stage VI oocytes were incubated in vehicle control, or indicated concentrations of
DHEA, and monitored for induction of apoptosis at indicated times. Below, are
representative images of oocytes at 8 hrs. Black arrowhead illustrates an example oocyte
undergoing apoptosis, indicated by the appearance of the ‘white dot’ on the animal pole.
B) Stage VI oocytes were injected with either vehicle control or 20 mM CoA and incubated
in the presence or absence of 1 µM DHEA. Oocytes were monitored for induction of
apoptosis at indicated times. Below, are representative images of oocytes at 7 hrs.
C). Stage VI oocytes were injected with either vehicle control, 20 mM CoA alone, or 20 mM
CoA and 1 mM CAMBD peptide, and incubated in the presence or absence of 1 µM DHEA.
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Oocytes were monitored for induction of apoptosis at indicated times. Below, are
representative images of oocytes at 11 hrs.
D) Mouse oocytes were aged for 12 hrs, incubated in 100 µM DHEA for 12 hours, and
stained for caspase-3 activity. See Table 1 for more details.
E) Mouse oocytes were microinjected with 5 mM CoA, aged for 12 hrs and then incubated ±
100 µM DHEA. Oocytes were stained for caspase-3 activity. The white arrowhead indicates
an area of non-specific staining. See table 1 for more details.
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Table 1
CoA inhibits DHEA induced death in aged mouse oocytes
Mouse oocytes were injected with vehicle control or indicated concentrations of CoA. Injected oocytes were
subsequently aged by incubation in KSOM supplemented with 0.1% PVA for 12 hrs, prior to incubation in the
absence or presence of 100 µM DHEA for a further 12 hrs, and monitored for morphological changes. The
significance of the difference between the treatment groups was tested using the Chi-square test. A p-value of
<0.05 was considered significant. A significant difference between the treatment groups (p<0.0001) was
observed. Oocytes were also stained with caspase-3 antibody. (See Figure 7).
Treatment
Total %
Dead
Control 111 0
DHEA 166 47.5
CoA 5 mM 30 0
CoA 5 mM + DHEA 32 12.5
Fra- Fragmentation; C3P- Caspase-3 Positive
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